Recruiting
Phase 2

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Sponsor:

Dickran Kazandjian, MD

Code:

NCT06376526

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Linvoseltamab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information